AFFY

Affymax, Inc. AFFY

AFFY
Affymax, Inc. BSSP
Baseline Productions, Inc. MRZM
Marizyme, Inc. AXMP
AXM Pharma, Inc. ACBM
Acro Biomedical Co., Ltd. ENDV
Endonovo Therapeutics, Inc. MLPH
Molecular Pharmacology (USA), Ltd. SXHHF
Sonomax Technologies Inc HAVLF
HAVN Life Sciences Inc. CNBX
CNBX Pharmaceuticals Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode AFFY BSSP MRZM AXMP ACBM ENDV MLPH SXHHF HAVLF CNBX
6M 200.00 % 9 900.00 % 0.00 % 9 900.00 % -30.00 % -66.67 % -25.00 % 0.00 % -90.00 % -94.79 %
YTD 200.00 % 9 900.00 % -96.34 % 9 900.00 % -30.00 % -85.71 % 200.00 % 0.00 % -90.00 % -95.00 %
1Y 242.86 % 0.00 % -99.25 % 9 900.00 % -30.00 % -88.89 % 200.00 % 0.00 % 0.00 % -94.71 %
3Y 140.00 % 0.00 % -99.98 % 0.00 % -99.98 % -98.70 % -57.14 % 9 900.00 % -99.81 % -99.99 %
5Y -98.90 % 0.00 % -99.99 % -50.00 % -99.98 % -99.86 % -90.63 % 9 900.00 % -100.00 % -100.00 %
10Y -97.37 % -95.24 % -99.67 % -99.49 % -99.98 % -100.00 % -97.12 % 9 900.00 % -100.00 % -99.99 %
From the beginning -99.99 % -99.98 % -99.97 % -99.49 % -99.98 % -100.00 % -97.60 % 9 900.00 % -100.00 % -100.00 %

Dividend

Affymax, Inc.